Destaques
Estudo mostra que é comum o excesso de tratamento em pacientes com diabetes tipo 2 residentes em casas de repouso.
31 Mar, 2022 | 13:30hComentários:
Overtreatment of T2DM Common Among VA Nursing Home Residents – HealthDay
Diabetes treatment deintensification uncommon in nursing home residents – medwire News
M-A | Anormalidades do parênquima pulmonar após internação por COVID-19 e pneumonite viral.
31 Mar, 2022 | 13:29hAnálise sistemática para o Global Burden of Disease 2019 Study | Impacto global, regional e nacional de doenças e lesões para adultos de 70 anos de idade ou mais.
31 Mar, 2022 | 13:27h
Comentário no Twitter
See our new paper prepared within @IHME_UW! #BMJ
Life expectancy ≥70 has continued to rise globally. #Disability burden remained constant, suggesting the need to enhance public health and intervention programmes to improve wellbeing among older adults.https://t.co/TegmWQ3048
— Maciej Banach (@maciejbanach) March 14, 2022
Estudo randomizado por cluster | Uma intervenção domiciliar de substituição do sal é custo-efetiva para a prevenção de AVC e melhorar a qualidade de vida.
29 Mar, 2022 | 15:17hComentário: ACC: Use of Salt Substitute to Prevent Stroke Is Cost-Saving – HealthDay
Conteúdos relacionados:
Former CDC director: Low sodium salt could save millions of lives – CNN
Is salt good for you after all? The evidence says no.
Systematic Review: Altered dietary salt intake for people with chronic kidney disease.
New WHO benchmarks help countries reduce salt intake and save lives.
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels
Estudo de coorte | Doença cardíaca e da artéria coronária são comuns em pacientes com infarto do miocárdio tipo 2.
29 Mar, 2022 | 15:15h
Comentário no Twitter
#OriginalResearch: #DEMAND_MI 1st prospective study to undertake systematic cardiac imaging in patients with type 2 MI. Results show high prevalence of LV dysfunction & CAD @damini_dey @imagingmedsci @marcdweck @jdinaus @andabularga @RyanWereski @chapdoc1 https://t.co/dygODQ92vs pic.twitter.com/ny3Fsyx7wH
— Circulation (@CircAHA) March 28, 2022
Opinião | Vacinação global deve ser mais rápida.
29 Mar, 2022 | 15:14hGlobal vaccination must be swifter – Nature
Miocardite e pericardite após vacinação contra COVID-19: diretriz para profissionais da saúde.
29 Mar, 2022 | 15:13hConteúdos relacionados:
Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.
Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.
Myocarditis after BNT162b2 vaccination in Israeli adolescents.
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Diretrizes brasileiras para o tratamento de pacientes ambulatoriais com COVID-19 suspeita ou confirmada.
29 Mar, 2022 | 15:10hEstudo de coorte | Uso paterno de metformina antes da concepção está associado a risco aumentado de problemas congênitos nos descendentes.
29 Mar, 2022 | 15:08hPreconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comentários:
Metanálise de estudos randomizados | Agonistas receptores de GLP1 aumentam o risco de doenças de vias biliares e vesícula biliar (RR 1,37; IC 95%, 1,23-1,52).
29 Mar, 2022 | 15:07hAssociation of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials – JAMA Internal Medicine (gratuito por tempo limitado)
Commentary: GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?— Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug – MedPage Today (gratuito por tempo limitado)